#137 – Paul Offit, M.D.: An expert perspective on COVID-19 vaccines
“When people talk to me about how nervous they are that antibodies are fading, I’m not sure you should be nervous about it yet. Let’s wait to see what happens as we move forward with these vaccines.” — Paul Offit
#136 – AMA #17: Body composition methods tour de force, insulin resistance, and Topo Chico
“Skeletal muscles are the greatest reservoir that you have for glucose disposal.” —Peter Attia
#135 – BJ Miller, M.D.: How understanding death leads to a better life
“People die much more miserable than they need to because they haven’t dared to look at this thing called death before it’s too late.” —BJ Miller
#134 – James O’Keefe, M.D.: Preventing cardiovascular disease and the risk of too much exercise
“If exercise were a drug, it would be the best drug we have for preventing heart disease . . .. But like with any drug, you’ve got to get the dose right.” — James O’Keefe
#133 – Vinay Prasad, M.D., M.P.H: Hallmarks of successful cancer policy
“The more you practice medicine, the more you realize that it’s an art. . .You’re going to have to make decisions today with less than perfect information.” —Vinay Prasad
#132 – AMA #16: Exploring hot and cold therapy
“All of the work that went into this analysis earlier in the year, it really changed my tune. And I think I’m now at the point where I kind of want to have a sauna, frankly, in the tool kit for longevity.” — Peter Attia
#131 – Beth Lewis: The Art of Stability: Learning about pain, mitigating injury, and moving better through life
“The only time it’s bad posture is when you don’t have another option.” —Beth Lewis
#130 – Carol Tavris, Ph.D. & Elliot Aronson, Ph.D.: Recognizing and overcoming cognitive dissonance
“If someone really is certain about something, they have almost certainly frozen their ability to change their minds when they need to.” – Carol Tavris
#129 – Tom Dayspring, M.D.: The latest insights into cardiovascular disease and lipidology
“Atherogenic lipoproteins are really the issue behind clinical atherosclerotic vascular disease. … The data has just become so overwhelming.” —Tom Dayspring
#128 – Irene Davis, Ph.D.: Evolution of the foot, running injuries, and minimalist shoes
“Rather than have the runners adapt to the running, they took the shoe and adapted it to the runner.” — Irene Davis